All In Biotech

Free tool

FAERS Monitor: Xofigo

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 203971 or its brand name (Xofigo, Radium Ra-223 Dichloride). Reports on generic versions are filed under their own applications.

Reports

5,055

Serious

4,481

89% of reports

Hospitalization

1,171

Death reported

1,036

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • prostatic specific antigen increased482
  • death450
  • hormone-refractory prostate cancer436
  • metastases to bone327
  • general physical health deterioration310
  • anaemia285
  • fatigue278
  • haemoglobin decreased243
  • nausea239
  • pain234
  • disease progression226
  • prostate cancer221
  • diarrhoea213
  • malaise209
  • asthenia197

Reports by year received

View as table
YearReports
201377
2014264
2015365
2016417
2017697
2018719
2019581
2020363
2021496
2022309
2023230
2024262
2025168
2026107

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,049,104 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hormone-refractory prostate cancerSignal4362414.22152.6664,257
prostatic specific antigen increasedSignal482150.8138.369,121
metastases to boneSignal32784.676.126,402
prostate cancerSignal22111.510.12,102
general physical health deteriorationSignal31011.210.02,870
haemoglobin decreasedSignal2439.98.71,933
disease progressionSignal2268.07.01,374
anaemiaSignal2856.25.61,254
astheniaSignal1972.21.9127
deathSignal4502.22.0296
malaise2092.01.7103
pain2341.61.451
fatigue2781.51.345
diarrhoea2131.41.222
nausea2391.31.113

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.